| | 133352-27-9 Basic information More.. |
| Product Name: | lydicamycin | | Synonyms: | lydicamycin;1-Pyrrolidinecarboximidamide, 2-[21-[1-[(2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)carbonyl]-1,2,4a,5,6,7,8,8a-octahydro-5,6-dihydroxy-1,3-dimethyl-2-naphthalenyl]-2,6,10,14,18-pentahydroxy-5,11,17,19-tetramethyl-4,8,12,16-heneicosatetraen-1-yl]- | | CAS: | 133352-27-9 | | MF: | C47H74N4O10 | | MW: | 855.12 | | EINECS: | | | Mol File: | 133352-27-9.mol |  |
Use
Lydicamycin belongs to a novel structural class with highly selective antibiotic activity. Recent research has shown that lydicamycin and the related metabolites, TPU-0037-A and TPU-0037-C, are highly active against MRSA. Lydicamycin is also closely related to BN 4515N which was isolated from a strain of Microtetraspora as a neuritogenic agent.
- Lydicamycin
-
- US $1140.00 / μg
- 2025-07-19
- CAS:133352-27-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
|
133352-27-9
Recommend Suppliers |
|